Results     18-May-20
Announcements
Astrazeneca Pharma India standalone net profit declines 2.44% in the March 2020 quarter
Sales rise 2.42% to Rs 194.90 crore
Net profit of Astrazeneca Pharma India declined 2.44% to Rs 9.58 crore in the quarter ended March 2020 as against Rs 9.82 crore during the previous quarter ended March 2019. Sales rose 2.42% to Rs 194.90 crore in the quarter ended March 2020 as against Rs 190.30 crore during the previous quarter ended March 2019.

For the full year,net profit rose 32.64% to Rs 72.21 crore in the year ended March 2020 as against Rs 54.44 crore during the previous year ended March 2019. Sales rose 14.21% to Rs 831.81 crore in the year ended March 2020 as against Rs 728.29 crore during the previous year ended March 2019.

ParticularsQuarter EndedYear Ended
 Mar. 2020Mar. 2019% Var.Mar. 2020Mar. 2019% Var.
Sales194.90190.30 2 831.81728.29 14
OPM %7.593.35 -14.519.79 -
PBDT17.8912.38 45 132.5487.58 51
PBT13.358.47 58 113.9672.66 57
NP9.589.82 -2 72.2154.44 33

Previous News
  Astrazeneca Pharma India standalone net profit rises 156.57% in the December 2022 quarter
 ( Results - Announcements 11-Feb-23   07:33 )
  AstraZeneca Pharma receives DCGI approval for launch of Benralizumab (Fasenra™) in India
 ( Corporate News - 21-Dec-20   08:55 )
  AstraZeneca Pharma India and Mankind Pharma ink distribution agreement
 ( Corporate News - 11-Mar-24   15:39 )
  Astrazeneca Pharma India standalone net profit rises 60.84% in the September 2023 quarter
 ( Results - Announcements 10-Nov-23   07:33 )
  Astrazeneca Pharma India standalone net profit declines 46.08% in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   07:42 )
  Astrazeneca Pharma India set to launch XIGDUO XR®
 ( Corporate News - 14-Dec-17   16:34 )
  Astrazeneca Pharma India Ltd leads losers in 'A' group
 ( Hot Pursuit - 09-Feb-24   15:00 )
  Astrazeneca Pharma India fixes record date for final dividend
 ( Market Beat - Reports 26-Jun-24   09:51 )
  AstraZeneca Pharma India hits 52-week low
 ( Hot Pursuit - 18-Feb-22   14:51 )
  Astrazeneca Pharma slips as Sebi says exchanges to monitor delisting
 ( Hot Pursuit - 25-Jun-14   10:16 )
  Astrazeneca Pharma India reports net loss of Rs 18.58 crore in the March 2013 quarter
 ( Results - Announcements 03-May-13   09:43 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top